COFS Q1 2026 Earnings EPS Beats Estimates by 55 Amid Mixed Market Reaction VYGR Q1 2026 Earnings Adjusted Loss Narrower Than Expected Despite No Revenue ANIX Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response XYF Q1 2020 Earnings Massive EPS Miss Amidst Pandemic Uncertainty PM Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Pricing and Volume Mix Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanAnticipated Loss Masks Progress in CART Pipeline